T1	Outcomes 613 641	The median serum MMP-8 level
T2	Outcomes 755 779	subgroup, IFN-α therapy
T3	Outcomes 794 831	improved relapse-free survival (RFS).
T4	Outcomes 869 886	high MMP-8 levels
T5	Outcomes 913 920	whereas
T6	Outcomes 940 957	high MMP-8 levels
T7	Outcomes 1001 1008	0.027).
T8	Outcomes 1009 1032	Median overall survival
T9	Outcomes 1051 1061	high MMP-8
T10	Outcomes 1167 1188	model, IFN-α therapy
T11	Outcomes 1220 1229	favorable
T12	Outcomes 1600 1621	with high serum MMP-8
